Cited by 607

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure

Lee, William M., Hynan, Linda S., Rossaro, Lorenzo, Fontana, Robert J., Stravitz, R. Todd, Larson, Anne M., Davern, Timothy J., Murray, Natalie G., McCashland, Timothy, Reisch, Joan S., Robuck, Patricia R.·2009·Gastroenterology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2009.06.006

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a randomized placebo-controlled trial of adult non-APAP acute liver failure (including DILI as the etiology), intravenous N-acetylcysteine improved transplant-free survival in early stage acute liver failure with grade I-II coma.

    “In a randomized placebo-controlled trial of adult non-APAP ALF (including DILI as the etiology), intravenous NAC improved transplant-free survival in early stage ALF with grade I-II coma [185].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 24

  1. Lee, 1993, Medical progress: acute liver failure, N Engl J Med, 329, 1862, 10.1056/NEJM199312163292508 · DOI
  2. Polson, 2005, American Association for the Study of Liver Disease position paper: the management of acute liver failure, Hepatology, 41, 1179, 10.1002/hep.20703 · DOI
  3. Rakela, 1991, A double-blinded, randomized trial of hydrocortisone in acute hepatic failure, Dig Dis Sci, 36, 1223, 10.1007/BF01307513 · DOI
  4. Rake, 1971, Early and intensive therapy of intravascular coagulation in acute liver failure, Lancet, ii, 1215, 10.1016/S0140-6736(71)90540-X · DOI
  5. Harrison, 1990, Failure of insulin and glucagon infusions to stimulate liver regeneration in fulminant hepatic failure, J Hepatol, 10, 332, 10.1016/0168-8278(90)90141-D · DOI
  6. Sinclair, 1991, Treatment of fulminant viral hepatic failure with prostaglandin E, Dig Dis Sci, 36, 791, 10.1007/BF01311239 · DOI
  7. Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med, 137, 945, 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
  8. Prescott, 1983, The treatment of acetaminophen poisoning, Annu Rev Pharmacol Toxicol, 23, 87, 10.1146/annurev.pa.23.040183.000511 · DOI
  9. Hamlyn, 1978, The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies, Postgrad Med J, 54, 400, 10.1136/pgmj.54.632.400 · DOI
  10. Rumack, 1984, Acetaminophen overdose in young children, Am J Dis Child, 138, 428, 10.1001/archpedi.1984.02140430006003 · DOI
  11. Makin, 1995, A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–1993), Gastroenterology, 109, 1907, 10.1016/0016-5085(95)90758-0 · DOI
  12. Walsh, 1998, The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure, Hepatology, 27, 1332, 10.1002/hep.510270520 · DOI
  13. Rank, 2000, N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study, Crit Care Med, 28, 3799, 10.1097/00003246-200012000-00006 · DOI
  14. Schneider, 1994, In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure, Hepatology, 19, 38, 10.1002/hep.1840190108 · DOI
  15. Zwingmann, 2006, Metabolic insights into the hepatoprotective effect of N-acetylcysteine in mouse liver, Hepatology, 443, 454, 10.1002/hep.21075 · DOI
  16. Hein, 2004, N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report, Crit Care, 8, R66, 10.1186/cc2426 · DOI
  17. Sklar, 2004, Acetylcysteine treatment for non-acetaminophen-induced acute liver failure, Ann Pharmacother, 38, 498, 10.1345/aph.1D209 · DOI
  18. Davern, 2006, Measurement of serum acetaminophen-protein adducts in patients with acute liver failure, Gastroenterology, 130, 687, 10.1053/j.gastro.2006.01.033 · DOI · Paper page
  19. James, 2006, Detection of acetaminophen-protein adducts in children with acute liver failure of indeterminate cause, Pediatrics, 118, 676, 10.1542/peds.2006-0069 · DOI
  20. Wiesner, 2003, Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, 124, 91, 10.1053/gast.2003.50016 · DOI
  21. Kremers, 2004, MELD score as a predictor of pre-transplant and posttransplant survival in OPTN/UNOS status 1 patients, Hepatology, 39, 764, 10.1002/hep.20083 · DOI
  22. Zaman, 2006, MELD score as a prognostic model for listing acute liver failure patients for liver transplantation, Transplant Proc, 38, 2097, 10.1016/j.transproceed.2006.06.004 · DOI
  23. Katoonizadeh, 2007, MELD score to predict outcome in adult patients with non-acetaminophen induced acute liver failure, Liver Int, 27, 329, 10.1111/j.1478-3231.2006.01429.x · DOI
  24. Kortsalioudaki, 2008, Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure, Liver Transpl, 14, 25, 10.1002/lt.21246 · DOI

Cited by

Sorted by citations

Metadata

Authors
Lee, W. M., Hynan, L. S., Rossaro, L., Fontana, R. J., Stravitz, R. T., Larson, A. M., Davern, T. J., Murray, N. G., McCashland, T., Reisch, J. S., & Robuck, P. R.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2009-09
Volume
137
Issue
3
Pages
856-864.e1
ISSN
0016-5085
Cited by
607
References
3
Language
en
Update notices
erratum (2013-09-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review